DUBLIN - May 2, 2016 - Medtronic plc (MDT) today announced the U.S. Food and Drug Administration (FDA) clearance of StrataMR(TM) valves and shunts, an addition to Medtronic`s family of Strata® ...

Medtronic PLC has voluntarily recalled all unused units of StrataMR adjustable valves and shunts used to manage hydrocephalus because of a problem that can occur after implantation that can lead to ...

Medtronic plc (NYSE: MDT) revealed the FDA clearance of StrataMR valves and shunts, an addition to its family of Strata Adjustable Valve Systems used in the treatment of patients with hydrocephalus ...

Medtronic has pulled all unused units of the StrataMR valves and shunts from the market after logging an increase in product complaints, including one reported patient death. Qmed Staff Report ...

DUBLIN - April 6, 2017 - Medtronic plc (MDT) today announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR(TM) adjustable valves and shunts.

A recent market study published by the company – “Hydrocephalus Shunt Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” – consists of a comprehensive assessment of the ...

Three magnetically programmable shunt valves have been examined to see if the magnetic field emissions of headphones can cause unintentional changes in shunt valve settings. Based on their findings, ...

Patients with Hydrocephalus and CSF Disorders Have Greater Access to Full Body MRI Scans with StrataMR DUBLIN - May 2, 2016 - Medtronic plc (MDT) today announced the U.S. Food and Drug Administration ...

Medtronic plc MDT revealed the FDA clearance of StrataMR valves and shunts, an addition to its family of Strata Adjustable Valve Systems used in the treatment of patients with hydrocephalus and ...

Medtronic plc (NYSE: MDT) today announced that on February 22, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR adjustable valves and shunts. These products are ...